These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 27698552)

  • 41. Adalimumab for childhood onset uveitis.
    Ramanan AV; Guly C
    Ann Rheum Dis; 2018 Jul; 77(7):961-962. PubMed ID: 29490981
    [No Abstract]   [Full Text] [Related]  

  • 42. Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.
    Horneff G
    Expert Opin Drug Saf; 2015 Jul; 14(7):1111-26. PubMed ID: 26084637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical features and therapy of uveitis in childhood].
    Kiss J; Gaál V; Nyul Z; Mosdósi B
    Orv Hetil; 2019 Aug; 160(34):1335-1339. PubMed ID: 31423830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results.
    Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Januschowski K; Voykov B; Deuter C
    Br J Ophthalmol; 2014 Apr; 98(4):523-8. PubMed ID: 24457365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
    J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managing juvenile idiopathic arthritis-associated uveitis.
    Hawkins MJ; Dick AD; Lee RJ; Ramanan AV; Carreño E; Guly CM; Ross AH
    Surv Ophthalmol; 2016; 61(2):197-210. PubMed ID: 26599495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
    Benitah NR; Sobrin L; Papaliodis GN
    Semin Ophthalmol; 2011; 26(4-5):295-303. PubMed ID: 21958178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?
    Tappeiner C; Heinz C; Ganser G; Heiligenhaus A
    J Rheumatol; 2012 Jun; 39(6):1294-5. PubMed ID: 22661419
    [No Abstract]   [Full Text] [Related]  

  • 50. [Autoimmune aspects of treatment with TNF-alpha inhibitors].
    Kolarz B; Targońska-Stepniak B; Darmochwał-Kolarz D; Majdan M
    Postepy Hig Med Dosw (Online); 2007 Aug; 61():478-84. PubMed ID: 17786135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?
    Anink J; Otten MH; Gorter SL; Prince FH; van Rossum MA; van den Berg JM; van Pelt PA; Kamphuis S; Brinkman DM; Swen WA; Swart JF; Wulffraat NM; Dolman KM; Koopman-Keemink Y; Hoppenreijs EP; Armbrust W; ten Cate R; van Suijlekom-Smit LW
    Rheumatology (Oxford); 2013 Sep; 52(9):1674-9. PubMed ID: 23740187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus.
    Bou R; Adán A; Borrás F; Bravo B; Calvo I; De Inocencio J; Díaz J; Escudero J; Fonollosa A; de Vicuña CG; Hernández V; Merino R; Peralta J; Rúa MJ; Tejada P; Antón J
    Rheumatol Int; 2015 May; 35(5):777-85. PubMed ID: 25656443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of Anti-TNF-α Therapy for the Treatment of Non-infectious Uveitis: A Retrospective Study of 21 Patients.
    Mercier AE; Ribeiro E; Korobelnik JF; Delyfer MN; Rougier MB
    Ocul Immunol Inflamm; 2018; 26(3):477-484. PubMed ID: 27775458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adalimumab: A Review in Non-Infectious Non-Anterior Uveitis.
    Hoy SM
    BioDrugs; 2017 Apr; 31(2):135-142. PubMed ID: 28229433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adalimumab in the treatment of non-infectious uveitis.
    Burek-Michalska A; Turno-Kręcicka A
    Adv Clin Exp Med; 2020 Oct; 29(10):1231-1236. PubMed ID: 33125196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The current status of biological treatment for uveitis.
    Gaggiano C; Sota J; Gentileschi S; Caggiano V; Grosso S; Tosi GM; Frediani B; Cantarini L; Fabiani C
    Expert Rev Clin Immunol; 2020 Aug; 16(8):787-811. PubMed ID: 32700605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.
    Acharya NR; Ebert CD; Kelly NK; Porco TC; Ramanan AV; Arnold BF;
    Trials; 2020 Oct; 21(1):887. PubMed ID: 33109240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recalcitrant psoriatic uveitis and anti-tumor necrosis factor-α monoclonal antibodies: experience from a psoriasis referral center.
    Fotiadou C; Lazaridou E; Kemanetzi C; Kyrmanidou E; Ioannides D
    Int J Dermatol; 2015 Sep; 54(9):1105-8. PubMed ID: 25557117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of chronic noninfectious uveitis in children--the trend toward tumor necrosis factor-alpha inhibition.
    Cunningham ET
    J AAPOS; 2013 Oct; 17(5):451-3. PubMed ID: 24160960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.